University of New Mexico

UNM Digital Repository
NotiSur

Latin America Digital Beat (LADB)

12-10-1991

Chile: On Impact Of Patent Protection Legislation
Reform
Barbara Khol

Follow this and additional works at: https://digitalrepository.unm.edu/notisur
Recommended Citation
Khol, Barbara. "Chile: On Impact Of Patent Protection Legislation Reform." (1991). https://digitalrepository.unm.edu/notisur/7860

This Article is brought to you for free and open access by the Latin America Digital Beat (LADB) at UNM Digital Repository. It has been accepted for
inclusion in NotiSur by an authorized administrator of UNM Digital Repository. For more information, please contact amywinter@unm.edu.

LADB Article Id: 063691
ISSN: 1060-4189

Chile: On Impact Of Patent Protection Legislation Reform
by Barbara Khol
Category/Department: General
Published: Tuesday, December 10, 1991
On Sept. 30, new legislation on comprehensive patent protection for foreign companies'
products went into effect. Local pharmaceutical firms have been sued by foreign companies for
manufacturing medicines and other items patented in the US and Europe. According to Economy
Minister Alejandro Reyes, "The pharmaceutical patent law disputes lit a fire under the issue.
But, in fact, an overhaul of our 50-year-old industrial property law was long overdue." Reyes
believes the new legislation will attract not only pharmaceutical transnationals, but also fiber
optics and communications technologies from Spain and Italy, sophisticated mining techniques
from Scandinavia, and bioengineering technologies from the US. Jorge Velis, general manager of
Laboratorio Upjohn Cia, Ltda., and past president of the local pharmaceutical lobby organization,
said, "Upjohn, Schering Plough, Parke-Davis, and Roche have already begun increasing investments
[in Chile]. The scope of their Chilean operations has grown as a result of the new law...Merck Sharp,
Bristol Meyer-Squibb, and Sanoffi [France] will be entering the national market soon." Bristol
Meyer-Squibb is currently negotiating an agreement with the local Laboratorios Recalcine S.A.
Recalcine already distributes for Proctor & Gamble and other foreign companies. Next, Laboratoire
Delagrange (France) is marketing an anti-depressant through Laboratorio Chile. Merke Sharp &
Dohme is teaming up with Laboratorios Saval. According to Velis, local companies who fail to join
forces with multinationals will soon be out of business. He said, "They won't be able to compete
once they have to pay royalties...Thirty foreign pharmaceutical MNCs are already doing business
in Chile, and 12 are US-based. The numbers will grow." Velis argues that if the highly competitive
domestic market (US$220 million per year) can attract so many MNCs, pharmaceuticals exports
to Latin American nations may follow. Despite positive results, Velis said the new legislation falls
short on two counts. First, patent protection is provided for only 15 years, and the norm is 20. Next,
the legislation applies to new patents only, or those registered after Sept. 30, 1991. [Basic data from
11/28/91 report by Chilean Information Project (CHIP, Santiago, Chile)]
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